A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma
Clinical trial NCT06739213 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06739213
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-31
- Primary completion
- 2027-01-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.